Sangamo Therapeutics
SGMO
#7081
Rank
C$0.54 B
Marketcap
$2.62
Share price
-4.08%
Change (1 day)
405.36%
Change (1 year)

P/S ratio for Sangamo Therapeutics (SGMO)

P/S ratio as of November 2024 (TTM): 32.0

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 16.6. At the end of 2024 the company had a P/S ratio of 6.06.

P/S ratio history for Sangamo Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.061007.68%
20230.5467-88.17%
20224.62-53.15%
20219.87-47.15%
202018.797.06%
20199.48-31.78%
201813.9-63.36%
201737.9241.21%
201611.1-31.62%
201516.2-29.06%
201422.9-36.08%
201335.8143.29%
201214.71.97%
201114.4-0.28%
201014.520.63%
200912.036.26%
20088.81-84.73%
200757.796.7%
200629.3-40.88%
200549.6-56.97%
2004115117.86%
200352.9208.67%
200217.1-63.37%
200146.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.04-87.35%๐Ÿ‡บ๐Ÿ‡ธ USA
15.1-52.81%๐Ÿ‡บ๐Ÿ‡ธ USA
4.87-84.77%๐Ÿ‡บ๐Ÿ‡ธ USA
2.38-92.55%๐Ÿ‡บ๐Ÿ‡ธ USA
0.7371-97.69%๐Ÿ‡บ๐Ÿ‡ธ USA
4.26-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
4.45-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
4.02-87.43%๐Ÿ‡บ๐Ÿ‡ธ USA